Drugs / Bet v 1aF1
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01353924 Comparator | Aug 2011 → Aug 2012 | allergic disease | Medical University of Vienna | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bet v 1aF1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01353924 ↗ |
| Modality | Protein / enzyme biologic | “Bet v 1aF1 is a protein of 73 amino acid residues” NCT01353924 ↗ |
| Route | Subcutaneous | “an equimolar mixture will be injected subcutaneously” NCT01353924 ↗ |